Living a healthy lifestyle may help offset a person's genetic risk of dementia, according to new research. The study was led by the University of Exeter - simultaneo...

Roche showed off additional efficacy and safety data for fast-growing hemophilia A drug Hemlibra. (Roche) Roche’s Hemlibra has been growing at eye-catching spee...

England's National Institute for Health and Care Excellence has decided to back Alnylam's gene-silencing therapy Onpattro, following a thumbs-up to Ionis' rival med...

Credit: GSK via Flickr ViiV Healthcare, an HIV drugmaker majority owned by GlaxoSmithKline, released clinical data Wednesday showing its two-drug therapy was abl...

Whether Array is worth $11 billion for Pfizer is dependent on whether both Braftovi and Mektovi are needed in colorectal cancer. (Array BioPharma) One key incent...

Amarin will double its sales force for fish-oil derivative Vascepa on the back of a record six months of sales. (Pixabay) Amarin has been teasing big plans ...

Gilead said Tuesday it plans to submit its experimental arthritis treatment filgotinib for U.S. approval this year, a speedier-than-expected timeline that could shor...

Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven't had much hope that another treatment option will lengthen their li...